Catabolism of phenylalanine MCQs With Answer

The catabolism of phenylalanine is a vital biochemical pathway for B.Pharm students to master, linking amino acid metabolism, enzyme mechanisms, cofactor biochemistry and inborn errors like phenylketonuria (PKU). Phenylalanine is primarily converted to tyrosine by phenylalanine hydroxylase (PAH) with tetrahydrobiopterin (BH4) as cofactor; alternative transamination forms phenylpyruvate and downstream phenylacetate. Downstream tyrosine degradation yields fumarate and acetoacetate via enzymes such as 4-hydroxyphenylpyruvate dioxygenase and fumarylacetoacetase; defects cause disorders like alkaptonuria and tyrosinemia. It covers enzyme kinetics, BH4 regeneration, transamination side pathways, diagnostic biochemical markers (plasma phenylalanine, phenylketones by tandem MS) and clinical management including dietary restriction and sapropterin therapy. These MCQs emphasize clinical correlations, lab markers and treatment principles. Now let’s test your knowledge with 50 MCQs on this topic.

Q1. Which enzyme catalyzes the primary conversion of phenylalanine to tyrosine?

  • Phenylalanine hydroxylase
  • Aromatic L-amino acid decarboxylase
  • Phenylpyruvate transaminase
  • Tyrosine aminotransferase

Correct Answer: Phenylalanine hydroxylase

Q2. Which cofactor is essential for phenylalanine hydroxylase activity?

  • Tetrahydrobiopterin (BH4)
  • Pyridoxal phosphate (PLP)
  • Thiamine pyrophosphate (TPP)
  • Nicotinamide adenine dinucleotide (NAD+)

Correct Answer: Tetrahydrobiopterin (BH4)

Q3. A deficiency of dihydropteridine reductase primarily impairs regeneration of which molecule?

  • Tetrahydrobiopterin (BH4)
  • Pyridoxal phosphate (PLP)
  • Biotin
  • FADH2

Correct Answer: Tetrahydrobiopterin (BH4)

Q4. Classical phenylketonuria (PKU) is most commonly caused by mutations in the gene encoding:

  • Phenylalanine hydroxylase (PAH)
  • Tyrosine aminotransferase (TAT)
  • Homogentisate oxidase (HGD)
  • Fumarylacetoacetase (FAH)

Correct Answer: Phenylalanine hydroxylase (PAH)

Q5. Which diagnostic marker is most directly elevated in untreated PKU?

  • Plasma phenylalanine
  • Plasma tyrosine
  • Plasma homogentisic acid
  • Plasma fumarate

Correct Answer: Plasma phenylalanine

Q6. Alternative transamination of phenylalanine yields which keto-acid?

  • Phenylpyruvate
  • 4-Hydroxyphenylpyruvate
  • Fumarylacetoacetate
  • Phenylacetylglutamine

Correct Answer: Phenylpyruvate

Q7. Which therapy is a synthetic form of BH4 used in some PKU patients?

  • Sapropterin
  • Levocarnitine
  • S-adenosylmethionine
  • Allopurinol

Correct Answer: Sapropterin

Q8. The Guthrie test historically detected PKU via bacterial growth inhibition in presence of:

  • β-2-thienylalanine
  • p-Aminobenzoic acid
  • Galactose
  • Hydroxocobalamin

Correct Answer: β-2-thienylalanine

Q9. Which enzyme deficiency leads to accumulation of homogentisic acid and alkaptonuria?

  • Homogentisate oxidase
  • 4-Hydroxyphenylpyruvate dioxygenase
  • Fumarylacetoacetase
  • Phenylalanine hydroxylase

Correct Answer: Homogentisate oxidase

Q10. Tyrosine produced from phenylalanine is a precursor for which of the following molecules?

  • Catecholamines and melanin
  • Vitamin B12 and heme
  • Thyroid hormone exclusively
  • Glutathione and creatine

Correct Answer: Catecholamines and melanin

Q11. Which vitamin-derived cofactor is required for transamination reactions often involved in amino acid catabolism?

  • Pyridoxal phosphate (PLP)
  • Riboflavin (FAD)
  • Niacin (NAD+)
  • Biotin

Correct Answer: Pyridoxal phosphate (PLP)

Q12. Elevated levels of phenylacetate and phenylpropionate in urine are associated with:

  • Untreated phenylketonuria (PKU)
  • Homocystinuria
  • Alkaptonuria
  • Maple syrup urine disease

Correct Answer: Untreated phenylketonuria (PKU)

Q13. Which newborn screening technique is now commonly used to quantify phenylalanine levels?

  • Tandem mass spectrometry (MS/MS)
  • Western blotting
  • ELISA for PAH protein
  • Urine dipstick

Correct Answer: Tandem mass spectrometry (MS/MS)

Q14. BH4-responsive hyperphenylalaninemia indicates residual activity of which enzyme?

  • Phenylalanine hydroxylase
  • Homogentisate oxidase
  • 4-Hydroxyphenylpyruvate dioxygenase
  • Tyrosine hydroxylase

Correct Answer: Phenylalanine hydroxylase

Q15. What is the inheritance pattern of classic PAH-related PKU?

  • Autosomal recessive
  • Autosomal dominant
  • X-linked recessive
  • Mitochondrial

Correct Answer: Autosomal recessive

Q16. Which clinical feature is commonly associated with untreated PKU in infants?

  • Intellectual disability and seizures
  • Jaundice
  • Muscle hypertrophy
  • Hypoglycemia only

Correct Answer: Intellectual disability and seizures

Q17. Maternal PKU can cause which fetal complications if maternal phenylalanine is uncontrolled?

  • Microcephaly and congenital heart defects
  • Polydactyly
  • Sickle cell disease
  • Hirschsprung disease

Correct Answer: Microcephaly and congenital heart defects

Q18. Which enzyme acts on 4-hydroxyphenylpyruvate in tyrosine catabolism?

  • 4-Hydroxyphenylpyruvate dioxygenase (HPPD)
  • Homogentisate oxidase
  • Fumarylacetoacetase
  • Phenylalanine hydroxylase

Correct Answer: 4-Hydroxyphenylpyruvate dioxygenase (HPPD)

Q19. Deficiency of fumarylacetoacetase causes which metabolic disease?

  • Tyrosinemia type I
  • Alkaptonuria
  • PKU variant
  • Homocystinuria

Correct Answer: Tyrosinemia type I

Q20. Which accumulated metabolite is characteristic of tyrosinemia type I?

  • Succinylacetone
  • Homogentisic acid
  • Phenylpyruvate
  • Phenylacetate

Correct Answer: Succinylacetone

Q21. Which therapeutic agent inhibits 4-hydroxyphenylpyruvate dioxygenase and is used in hereditary tyrosinemia type I management?

  • NTBC (nitisinone)
  • Sapropterin
  • Allopurinol
  • Penicillamine

Correct Answer: NTBC (nitisinone)

Q22. PEG-PAL (pegylated phenylalanine ammonia lyase) is designed to:

  • Degrade circulating phenylalanine enzymatically
  • Enhance PAH gene expression
  • Block BH4 synthesis
  • Increase tyrosine hydroxylase activity

Correct Answer: Degrade circulating phenylalanine enzymatically

Q23. Large neutral amino acid (LNAA) supplementation in PKU therapy primarily works by:

  • Competing with phenylalanine for transport across the blood-brain barrier
  • Increasing renal excretion of phenylalanine
  • Activating PAH allosterically
  • Inhibiting intestinal absorption of phenylalanine

Correct Answer: Competing with phenylalanine for transport across the blood-brain barrier

Q24. Which laboratory ratio is useful in newborn screening to distinguish PKU from transient hyperphenylalaninemia?

  • Phenylalanine/tyrosine ratio
  • Tyrosine/phenylalanine ratio
  • Methionine/cysteine ratio
  • Leucine/isoleucine ratio

Correct Answer: Phenylalanine/tyrosine ratio

Q25. BH4 is synthesized de novo from which precursor molecule class?

  • GTP-derived pteridine pathway
  • Amino acid sulfur metabolism
  • Lipid-derived isoprenoids
  • Carbohydrate pentose pathway

Correct Answer: GTP-derived pteridine pathway

Q26. Which enzyme deficiency causes elevated urinary 4-hydroxyphenylpyruvate and tyrosine levels but not classic alkaptonuria?

  • 4-Hydroxyphenylpyruvate dioxygenase deficiency
  • Phenylalanine hydroxylase deficiency
  • Fumarylacetoacetase deficiency
  • Homogentisate oxidase deficiency

Correct Answer: 4-Hydroxyphenylpyruvate dioxygenase deficiency

Q27. In BH4 deficiency, besides hyperphenylalaninemia, patients may also have deficiency in synthesis of which neurotransmitters?

  • Dopamine and serotonin
  • GABA and glycine
  • Acetylcholine and histamine
  • Epinephrine exclusively

Correct Answer: Dopamine and serotonin

Q28. The biochemical basis for cognitive impairment in PKU is mainly due to:

  • Toxic effects of elevated brain phenylalanine and reduced tyrosine-derived neurotransmitters
  • Defective myelin synthesis from lack of methionine
  • Accumulation of homogentisic acid in the brain
  • Hypoglycemia from amino acid catabolism

Correct Answer: Toxic effects of elevated brain phenylalanine and reduced tyrosine-derived neurotransmitters

Q29. Which diagnostic assay directly measures PAH enzyme activity in cultured cells?

  • PAH activity assay using radiolabeled phenylalanine
  • ELISA for phenylalanine
  • Urine ketone strip test
  • Hemoglobin electrophoresis

Correct Answer: PAH activity assay using radiolabeled phenylalanine

Q30. What is the primary clinical rationale for supplementing tyrosine in PKU diets?

  • Tyrosine becomes an essential amino acid when phenylalanine conversion is impaired
  • Tyrosine directly lowers plasma phenylalanine by binding it
  • Tyrosine cures PAH gene mutations
  • Tyrosine increases BH4 synthesis

Correct Answer: Tyrosine becomes an essential amino acid when phenylalanine conversion is impaired

Q31. Which organ is the major site of phenylalanine catabolism?

  • Liver
  • Kidney
  • Brain
  • Skeletal muscle

Correct Answer: Liver

Q32. Which metabolite is produced by gut bacteria from excess phenylalanine and may contribute to odor in PKU?

  • Phenylacetate
  • Tyrosol
  • Urobilinogen
  • Indican

Correct Answer: Phenylacetate

Q33. In phenylalanine catabolism, conversion of phenylalanine to phenylpyruvate involves which enzyme type?

  • Aminotransferase (transaminase)
  • Hydroxylase
  • Monooxygenase
  • Carboxylase

Correct Answer: Aminotransferase (transaminase)

Q34. A high phenylalanine/tyrosine ratio in newborn screening suggests:

  • Impaired conversion of phenylalanine to tyrosine
  • Excess tyrosine intake
  • Fasting artifact only
  • Vitamin C deficiency

Correct Answer: Impaired conversion of phenylalanine to tyrosine

Q35. Which molecular therapy approach aims to correct PAH mutations at DNA level?

  • Gene therapy delivering functional PAH gene
  • BH4 supplementation
  • Dietary phenylalanine restriction
  • Enzyme replacement with PEG-PAL only

Correct Answer: Gene therapy delivering functional PAH gene

Q36. Which biochemical consequence is expected when BH4 levels are low?

  • Reduced PAH activity and increased plasma phenylalanine
  • Increased PLP-dependent transamination
  • Enhanced tyrosine degradation to fumarate
  • Decreased phenylacetate excretion only

Correct Answer: Reduced PAH activity and increased plasma phenylalanine

Q37. Heterozygous carriers of PAH mutations typically exhibit which phenotype?

  • Usually asymptomatic with normal phenylalanine metabolism
  • Classical PKU phenotype
  • Severe intellectual disability
  • Alkaptonuria features

Correct Answer: Usually asymptomatic with normal phenylalanine metabolism

Q38. An elevated urinary phenylketone in PKU indicates accumulation of which compound?

  • Phenylpyruvate
  • Homogentisic acid
  • Succinylacetone
  • Phenylalanine hydroxylase

Correct Answer: Phenylpyruvate

Q39. Which of the following is NOT a downstream product of tyrosine catabolism?

  • Phenylacetate
  • Fumarate
  • Acetoacetate
  • Homogentisic acid

Correct Answer: Phenylacetate

Q40. Which enzyme converts tyrosine to p-hydroxyphenylpyruvate?

  • Tyrosine aminotransferase
  • Tyrosine hydroxylase
  • Phenylalanine hydroxylase
  • Homogentisate oxidase

Correct Answer: Tyrosine aminotransferase

Q41. Which metabolic product causes the darkening of urine on standing in alkaptonuria?

  • Homogentisic acid
  • Phenylpyruvate
  • Succinylacetone
  • Phenylacetylglutamine

Correct Answer: Homogentisic acid

Q42. Which test provides a quantitative measurement of plasma phenylalanine concentration in a clinical lab?

  • Liquid chromatography–tandem mass spectrometry (LC-MS/MS)
  • Urine dipstick
  • Complete blood count
  • Serum electrolyte panel

Correct Answer: Liquid chromatography–tandem mass spectrometry (LC-MS/MS)

Q43. Which enzyme defect is directly targeted by nitisinone (NTBC) therapy?

  • 4-Hydroxyphenylpyruvate dioxygenase
  • Fumarylacetoacetase
  • Phenylalanine hydroxylase
  • Homogentisate oxidase

Correct Answer: 4-Hydroxyphenylpyruvate dioxygenase

Q44. Which amino acid becomes conditionally essential in PAH deficiency?

  • Tyrosine
  • Methionine
  • Tryptophan
  • Leucine

Correct Answer: Tyrosine

Q45. Plasma phenylalanine levels above which approximate concentration typically indicate classical PKU (untreated)?

  • >1200 µmol/L
  • 50–100 µmol/L
  • 200–400 µmol/L
  • <100 µmol/L

Correct Answer: >1200 µmol/L

Q46. Which molecular diagnostic method is commonly used to identify PAH gene mutations?

  • DNA sequencing of the PAH gene
  • Western blot for PAH protein
  • Urinalysis for phenylketones
  • Chromosomal karyotyping

Correct Answer: DNA sequencing of the PAH gene

Q47. Which pharmacologic strategy reduces cerebral phenylalanine toxicity by altering blood-brain transport?

  • Supplementation with large neutral amino acids (LNAA)
  • High-dose vitamin C
  • Iron chelation therapy
  • Steroid administration

Correct Answer: Supplementation with large neutral amino acids (LNAA)

Q48. Which clinical measurement is most important to monitor in children under dietary therapy for PKU?

  • Regular plasma phenylalanine concentrations
  • Serum sodium
  • Urine albumin
  • Fasting glucose

Correct Answer: Regular plasma phenylalanine concentrations

Q49. Enzymatic degradation of phenylalanine to trans-cinnamic acid is catalyzed by which therapeutic enzyme used experimentally?

  • Phenylalanine ammonia lyase (PAL)
  • Monoamine oxidase
  • Urocanase
  • Phenylalanine decarboxylase

Correct Answer: Phenylalanine ammonia lyase (PAL)

Q50. Which statement best summarizes the clinical importance of understanding phenylalanine catabolism for B.Pharm students?

  • It links biochemical pathways to diagnostic methods, genetic counseling and pharmacological management of disorders like PKU and tyrosinemia
  • It only concerns dietary recommendations with no drug implications
  • It is relevant only for basic science researchers and not pharmacists
  • It focuses solely on liver anatomy without clinical application

Correct Answer: It links biochemical pathways to diagnostic methods, genetic counseling and pharmacological management of disorders like PKU and tyrosinemia

Leave a Comment